Wealthcare Advisory Partners LLC Invitae Corp Transaction History

Wealthcare Advisory Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $134,211 - $261,757	-9,130 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $65,637 - $90,720	2,700 Added 41.99%	9,130 $260,000
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $146,104 - $226,240	5,600 Added 674.7%	6,430 $217,000
Q1 2021 Apr 30, 2021	BUY	$33.06 - $56.93 $27,439 - $47,251	830 New	830 $32,000
Q3 2018 Nov 14, 2018	SELL	$7.54 - $18.31 $37,700 - $91,550	-5,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$4.87 - $8.42 $24,350 - $42,100	5,000 New	5,000 $37,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.